232 related articles for article (PubMed ID: 29133555)
1. Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.
McLeod SM; Shapiro AB; Moussa SH; Johnstone M; McLaughlin RE; de Jonge BLM; Miller AA
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133555
[TBL] [Abstract][Full Text] [Related]
2. Targeting Multidrug-Resistant
Barnes MD; Kumar V; Bethel CR; Moussa SH; O'Donnell J; Rutter JD; Good CE; Hujer KM; Hujer AM; Marshall SH; Kreiswirth BN; Richter SS; Rather PN; Jacobs MR; Papp-Wallace KM; van den Akker F; Bonomo RA
mBio; 2019 Mar; 10(2):. PubMed ID: 30862744
[TBL] [Abstract][Full Text] [Related]
3. ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Durand-Réville TF; Guler S; Comita-Prevoir J; Chen B; Bifulco N; Huynh H; Lahiri S; Shapiro AB; McLeod SM; Carter NM; Moussa SH; Velez-Vega C; Olivier NB; McLaughlin R; Gao N; Thresher J; Palmer T; Andrews B; Giacobbe RA; Newman JV; Ehmann DE; de Jonge B; O'Donnell J; Mueller JP; Tommasi RA; Miller AA
Nat Microbiol; 2017 Jun; 2():17104. PubMed ID: 28665414
[TBL] [Abstract][Full Text] [Related]
4. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.
Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848013
[TBL] [Abstract][Full Text] [Related]
5.
McLeod SM; Moussa SH; Hackel MA; Miller AA
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988095
[No Abstract] [Full Text] [Related]
6. Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of
Moussa SH; Shapiro AB; McLeod SM; Iyer R; Carter NM; Tsai Y-K; Siu LK; Miller AA
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0066523. PubMed ID: 37843305
[No Abstract] [Full Text] [Related]
7. Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species.
Papp-Wallace KM; McLeod SM; Miller AA
Clin Infect Dis; 2023 May; 76(Suppl 2):S194-S201. PubMed ID: 37125470
[TBL] [Abstract][Full Text] [Related]
8. OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.
Yang Y; Xu Q; Li T; Fu Y; Shi Y; Lan P; Zhao D; Chen Q; Zhou Z; Jiang Y; Peleg AY; Yu Y
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348663
[No Abstract] [Full Text] [Related]
9. In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex.
McLeod SM; Carter NM; Bradford PA; Miller AA
Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116344. PubMed ID: 38735147
[TBL] [Abstract][Full Text] [Related]
10. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.
Penwell WF; Shapiro AB; Giacobbe RA; Gu RF; Gao N; Thresher J; McLaughlin RE; Huband MD; DeJonge BL; Ehmann DE; Miller AA
Antimicrob Agents Chemother; 2015 Mar; 59(3):1680-9. PubMed ID: 25561334
[TBL] [Abstract][Full Text] [Related]
12.
Rodriguez CH; Brune A; Nastro M; Vay C; Famiglietti A
J Med Microbiol; 2020 Jul; 69(7):928-931. PubMed ID: 32584214
[No Abstract] [Full Text] [Related]
13.
Karlowsky JA; Hackel MA; McLeod SM; Miller AA
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0078122. PubMed ID: 36005804
[TBL] [Abstract][Full Text] [Related]
14. Genome sequencing and molecular characterisation of XDR Acinetobacter baumannii reveal complexities in resistance: Novel combination of sulbactam-durlobactam holds promise for therapeutic intervention.
Naha A; Vijayakumar S; Lal B; Shankar BA; Chandran S; Ramaiah S; Veeraraghavan B; Anbarasu A
J Cell Biochem; 2021 Dec; 122(12):1946-1957. PubMed ID: 34597421
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
[TBL] [Abstract][Full Text] [Related]
16. Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.
Papp-Wallace KM; Senkfor B; Gatta J; Chai W; Taracila MA; Shanmugasundaram V; Han S; Zaniewski RP; Lacey BM; Tomaras AP; Skalweit MJ; Harris ME; Rice LB; Buynak JD; Bonomo RA
Antimicrob Agents Chemother; 2012 Nov; 56(11):5687-92. PubMed ID: 22908165
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
18. The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus Complex.
O'Donnell JP; Bhavnani SM
Clin Infect Dis; 2023 May; 76(Suppl 2):S202-S209. PubMed ID: 37125469
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
